Cargando…
A Synergistic Therapeutic Scheme for Hyperglycemia and Nephrotic Disorders in Diabetes
We previously demonstrated that the utilization of an electrospun scaffold could boost functional outputs of transplanted islets. In this study, we aim to develop a drug-eluting scaffold with a payload of pioglitazone to simultaneously rein in hyperglycemia and recoup lost renal functions in diabeti...
Autores principales: | He, Qingyi, Zhang, Xing, Han, Baosan, Xu, Jianzhong, Tang, Kanglai, Fu, Zhiren, Yin, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964444/ https://www.ncbi.nlm.nih.gov/pubmed/24669279 http://dx.doi.org/10.7150/thno.7847 |
Ejemplares similares
-
A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation
por: He, Qingyi, et al.
Publicado: (2013) -
The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders
por: Yong, Cai, et al.
Publicado: (2014) -
The Therapeutic Role of Monocyte Chemoattractant Protein-1 in a Renal Tissue Engineering Strategy for Diabetic Patients
por: Yin, Hao, et al.
Publicado: (2013) -
Hyperglycemia and Renal Mass Ablation Synergistically Augment Albuminuria in the Diabetic Subtotally Nephrectomized Rat: Implications for Modeling Diabetic Nephropathy
por: Chen, Li-Hao, et al.
Publicado: (2012) -
Diabetes and nephrotic syndrome: Questions
por: Gilbert, Rodney D, et al.
Publicado: (2017)